Pan-cancer analysis revealed that up-regulation of SLC10A3 is not only a risk factor for worse overall survival among LGGs (Figure 3A), but also a risk factor for inferior progression-free survival among LGGs (Figure 3B). Here, SLC10A3 is linked to cancer.